TerSera Therapeutics LLC Sustainability Profile
TerSera Therapeutics LLC, a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2015, the company has rapidly established itself as a leader in developing innovative therapies for patients with unmet medical needs, particularly in the areas of oncology and rare diseases. With a focus on precision medicine, TerSera's core products include advanced therapeutics that leverage cutting-edge research and technology, setting them apart in a competitive market. The company has achieved significant milestones, including strategic partnerships and successful product launches, which have solidified its position as a trusted name in the healthcare sector. TerSera Therapeutics continues to drive advancements in treatment options, demonstrating a commitment to improving patient outcomes and enhancing the quality of life for those they serve.
DitchCarbon Score
How does TerSera Therapeutics LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TerSera Therapeutics LLC's score of 32 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TerSera Therapeutics LLC's reported carbon emissions
In 2022, TerSera Therapeutics LLC reported total greenhouse gas emissions of approximately 31.4 million kg CO2e. This total comprises Scope 1 emissions of about 11.9 million kg CO2e, Scope 2 emissions of approximately 1.6 million kg CO2e, and Scope 3 emissions of around 17.9 million kg CO2e. The company has set ambitious targets to reduce its greenhouse gas emissions, aiming for a 50% reduction in Scope 1 and Scope 2 emissions by 2030, using a 2019 baseline. This commitment is part of their decarbonisation roadmap, reflecting a proactive approach to climate action. In 2021, TerSera's total emissions were approximately 25.2 million kg CO2e, indicating an increase in emissions in 2022. The company has not disclosed specific emissions data for 2019, but their ongoing initiatives demonstrate a commitment to sustainability and reducing their carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 11,477,000 | 00,000,000 |
| Scope 2 | 2,497,000 | 0,000,000 |
| Scope 3 | 11,268,000 | 00,000,000 |
How Carbon Intensive is TerSera Therapeutics LLC's Industry?
How Carbon Intensive is TerSera Therapeutics LLC's Location?
TerSera Therapeutics LLC's Scope 3 Categories Breakdown
TerSera Therapeutics LLC's Scope 3 emissions, which increased by 59% last year and increased by approximately 59% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 57% of total emissions under the GHG Protocol, with "Business Travel" being the largest emissions source at 31% of Scope 3 emissions.
Top Scope 3 Categories
TerSera Therapeutics LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
TerSera Therapeutics LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.